Active substance
Results for the substance pralsetinib
1 result
About this active substance
Pralsetinib is a medication used for the treatment of certain types of cancer, such as non-small cell lung cancer (NSCLC) and thyroid cancer, that have RET gene mutations. It is a RET kinase inhibitor that blocks abnormal cellular signaling, slowing tumor growth.
The medication is taken orally, usually in capsule form, and should be used as directed by your doctor. Regular check-ups are important to monitor the effectiveness of the treatment and any potential side effects.
Side effects may include fatigue, nausea, diarrhea, high blood pressure, or skin rashes. In rare cases, severe adverse effects such as liver or lung function impairment may occur, requiring immediate medical attention.
Patients should inform their doctor about any other medications being used or pre-existing conditions, such as hypertension or liver diseases, to ensure the safe use of pralsetinib.
The medication is taken orally, usually in capsule form, and should be used as directed by your doctor. Regular check-ups are important to monitor the effectiveness of the treatment and any potential side effects.
Side effects may include fatigue, nausea, diarrhea, high blood pressure, or skin rashes. In rare cases, severe adverse effects such as liver or lung function impairment may occur, requiring immediate medical attention.
Patients should inform their doctor about any other medications being used or pre-existing conditions, such as hypertension or liver diseases, to ensure the safe use of pralsetinib.